David Nutt
Chief Research Officer
Imperial College London
Prof. David Nutt is Chief Research Officer at Awakn Life Sciences, a biotechnology company, researching, developing, and commercializing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder.
He is a psychiatrist and the Edmund J. Safra Professor of Neuropsychopharmacology in the Division of Brain Sciences, Dept of Medicine, Imperial College London, where he uses a range of brain imaging techniques to explore the causes of addiction and other psychiatric disorders and to search for new treatments.